The genetics of serum lipid responsiveness to dietary interventions

Proceedings of the Nutrition Society

Volumn 58, Issue 1, 1999, Pages 171-187

  Ordovas, Jose M ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Cholesterol; Dietary fats; Genetics; Lipoproteins

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN B; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CHOLESTEROL BLOOD LEVEL; CLINICAL RESEARCH; CONFERENCE PAPER; DIET THERAPY; EXERCISE; FAT INTAKE; FOOD COMPOSITION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; HYPERCHOLESTEROLEMIA; LIFESTYLE; TREATMENT OUTCOME; WEIGHT REDUCTION;

APOLIPOPROTEIN C-III; APOLIPOPROTEINS A; APOLIPOPROTEINS B; APOLIPOPROTEINS C; APOLIPOPROTEINS E; CARDIOVASCULAR DISEASES; CARRIER PROTEINS; CHOLESTEROL ESTER TRANSFER PROTEINS; DIET; GLYCOPROTEINS; HUMANS; LIPIDS;

EID: 0032908524     PISSN: 00296651     EISSN: None     Source Type: Journal    
DOI: 10.1079/PNS19990023     Document Type: Conference Paper

References (186)

1. Aalto-Setälä K, Kontula K, Mänttäri M, Huttunen J, Manninen V, Koskinen P & Frick HM (1991) DNA polymorphisms of apolipoprotein B and AI/CIII genes and response to gemfibrozil treatment. Clinical Pharmacology and Therapeutics 50, 208-214.
2. Aalto-Setälä K, Tikkanen M, Taskinen MR, Nieminen M, Homberg P & Kontula K (1988) Xbal and c/g polymorphism of the apolipoprotein B gene locus are associated with serum cholesterol and LDL cholesterol levels in Finland. Atherosclerosis 74, 47-54.
3. Akita H, Chiba H, Tsuji M, Hui SP, Takahashi Y, Matsuno K & Kobayashi K (1995) Evaluation of G-to-A substitution in the apolipoprotein A-I gene promoter as a determinant of high-density lipoprotein cholesterol level in subjects with and without cholesteryl ester transfer protein deficiency. Human Genetics 96, 521-526.
4. Altshuler D, Kruglyak L & Lander E (1998) Genetic polymorphisms and disease. New England Journal of Medicine 338, 1626.
5. Angotti E, Mele E, Costanzo F & Avvedimento EV (1994) A polymorphism (G→A transition) in the -78 position of the apolipoprotein A-I promoter increases transcription efficiency. Journal of Biological Chemistry 269, 17371-17374.
6. Bai H, Saku K, Liu R, Funke H, Von Eckardstein A & Arakawa K (1993) Polymorphic site study at codon 347 of apolipoprotein A-IV in a Japanese population. Biochimica et Biophysica Acta 1174, 279-281.
7. Barre DE, Guerra R, Verstraete R, Wang Z, Grundy SM & Cohen JC (1994) Genetic analysis of a polymorphism in the human apolipoprotein A-I gene promoter: effect on plasma HDL-cholesterol levels. Journal of Lipid Research 35, 1292-1296.
8. Beisiegel U, Weber W, Ihrke G, Herz J & Stanley KK (1989) The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature 341, 162-164.
9. Berg K (1986) DNA polymorphism at the apolipoprotein B locus is associated with lipoprotein level. Clinical Genetics 30, 515-520.
10. Bergeron N & Havel RJ (1996) Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein ε4 allele. Journal of Clinical Investigation 97, 65-72.
11. Blackhart BD, Ludwig EM, Pierotti VR, Caiati L, Onasch MA, Powell L, Pease R, Knott TJ, Chu ML, Mahley RW, Scott J, McCarthy BJ & Levy-Wilson B (1986) Structure of the human apolipoprotein B gene. Journal of Biological Chemistry 261, 15364-15367.
12. Blankenhorn DH, Alaupovic P, Wickham E, Chin HP & Azen SP (1990) Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors. Circulation 81, 470-476.
13. Boerwinkle E, Brown SA, Rohrbach K, Gotto AM Jr & Patsch W (1991) Role of apolipoprotein E and B gene variation in determining response of lipid, lipoprotein, and apolipoprotein levels to increased dietary cholesterol. American Journal of Human Genetics 49, 1145-1154.
14. Boerwinkle E, Brown S, Sharrett AR, Heiss G & Patsch W (1994) Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations. American Journal of Human Genetics 54, 341-360.
15. Boerwinkle E & Chan L (1989) A three codon insertion/deletion polymorphism in the signal peptide region of the human apolipoprotein B gene directly typed by the polymerase chain reaction. Nucleic Acids Research 17, 4003.
16. Bohn M, Bakken A, Erikssen J & Berg K (1994) The apolipoprotein B signal peptide insertion/deletion polymorphism is not associated with myocardial infarction in Norway. Clinical Genetics 45, 255-259.
17. Bohn M & Berg K (1994) The Xbal polymorphism at the apolipoprotein B locus and risk of atherosclerotic disease. Clinical Genetics 46, 77-79.
18. Brown AJ & Roberts DCK (1991) The effect of fasting triacylglyceride concentration and apolipoprotein E polymorphism on postprandial lipemia. Arteriosclerosis and Thrombosis 11, 1737-1744.
19. Bruns GA, Karathanasis SK & Breslow JL (1984) Human apolipoprotein Al-CIII gene complex is located in chromosome 11. Arteriosclerosis 4, 97-104.
20. Byrne CD, Wareham NJ, Mistry PK, Phillips DIW, Martensz ND, Halsall D, Talmud PJ, Humphries SE & Hales CN (1996) The association between free fatty acid concentrations and triglyceride-rich lipoproteins in the postprandial state is altered by a common deletion polymorphism of the apoB signal peptide. Atherosclerosis 127, 35-42.
21. Campos H, Lopez-Miranda J, Rodriguez C, Albajar M, Schaefer EJ & Ordovas JM (1997) Urbanization elicits a more atherogenic lipoprotein profile in carriers of the apolipoprotein A-IV-2 allele than in A-IV-1 homozygotes. Arteriosclerosis, Thrombosis and Vascular Biology 17, 1074-1081.
22. Carlsson P, Darnfors C, Olofsson SO & Bjursell G (1986) Analysis of the human apolipoprotein B gene: complete structure of the B74 region. Gene 49, 29-51.
23. Carmena R, Roederer G, Mailloux H, Lussier-Cacan S & Davignon J (1993) The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism. Metabolism 42, 895-901.
24. Carmena-Ramon RF, Ascaso JF, Real JT, Ordovas JM & Carmena R (1998a) Genetic variation at the ApoA-IV gene locus and response to diet in familial hypercholesterolemia. Arteriosclerosis, Thrombosis and Vascular Biology 18, 1266-1274.
25. Carmena-Ramon RF, Ordovas JM, Ascaso JF, Real J, Priego MA & Carmena R (1998b) Influence of genetic variation at the apoA-I gene locus on lipid levels and response to diet in familial hypercholesterolemia. Atherosclerosis 139, 107-113.
26. Chamberlain JC, Thorn JA, Morgan R, Bishop A, Stocks J, Rees A, Oka K & Galton DJ (1991) Genetic variation at the lipoprotein lipase gene associates with coronary arteriosclerosis. Advances in Experimental Medicine and Biology 285, 275-279.
27. Civeira F, Pocovi M, Cenarro A, Garces C & Ordovas JM (1993) Adenine for guanine substitution -78 base pairs to the apolipoprotein(APO) A-I gene: relation with high density lipoprotein cholesterol and apoA-I concentrations. Clinical Genetics 44, 307-312.
28. Clifton PM, Abbey M, Noakes M, Beltrame S, Rumbelow N & Nestel PJ (1995) Body fat distribution is a determinant of the high-density lipoprotein response to dietary fat and cholesterol in women. Arteriosclerosis, Thrombosis and Vascular Biology 15, 1070-1078.
29. Cobb MM & Risch N (1993) Low-density lipoprotein cholesterol responsiveness to diet in normolipidemic subjects. Metabolism 42, 7-13.
30. Cobb MM, Teitlebaum H, Risch N, Jekel J & Ostfeld A (1992) Influence of dietary fat, apolipoprotein E phenotype, and sex on plasma lipoprotein levels. Circulation 86, 849-857.
31. Connor WE & Connor SL (1997a) Should a low-fat, high-carbohydrate diet be recommended for everyone? The case for a low-fat, high-carbohydrate diet. New England Journal of Medicine 337, 562-563.
32. Connor WE & Connor SL (1997b) Should a low-fat, high-carbohydrate diet be recommended for everyone? Discussion. New England Journal of Medicine 337, 566-567.
33. Crews DE, Kamboh MI, Mancilha-Carvalho JJ & Kottke B (1993) Population genetics of apolipoprotein A-4, E, and H polymorphisms in Yanomami Indians of northwestern Brazil: associations with lipids, lipoproteins, and carbohydrate metabolism. Human Biology 65, 211-224.
34. Dallongeville J & Fruchart JC (1998) Postprandial dyslipidemia: a risk factor for coronary heart disease. Annals of Nutrition and Metabolism 42, 1-11.
35. Dammerman M, Sandkuijl LA, Halaas JL, Chung W & Breslow JL (1993) An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3′ untranslated region polymorphisms. Proceedings of the National Academy of Sciences USA 90, 4562-4566.
36. Davignon J, Gregg RE & Sing CF (1988) Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 8, 1-21.
37. De Bruin TWA, Mailly F, Van Barlingen HHJJ, Fisher R, Cabezas MC, Talmud P, Dallinga-Thie GM & Humphries SE (1996) Lipoprotein lipase gene mutations D9N and N291S in four pedigrees with familial combined hyperlipidaemia. European Journal of Clinical Investigation 26, 631-639.
38. de Knijff P, Johansen LG, Rosseneu M, Frants RR, Jespersen J & Havekes LM (1992) Lipoprotein profile of a Greenland Inuit population. Influence of anthropometric variables, Apo E and A4 polymorphism, and lifestyle. Arteriosclerosis and Thrombosis 12, 1371-1379.
39. de Knijff P, Rosseneu M, Beisiegel U, De Keersgieter W, Frants RR & Havekes LM (1988) Apolipoprotein A-IV polymorphism and its effect on plasma lipid and apolipoprotein concentrations. Journal of Lipid Research 29, 1621-1627.
40. Dixon LB, Shannon BM, Tershakovec AM, Bennett MJ, Coates PM & Cortner JA (1997) Effects of family history of heart disease, apolipoprotein E phenotype, and lipoprotein(a) on the response of children's plasma lipids to change in dietary lipids. American Journal of Clinical Nutrition 66, 1207-1217.
41. Dreon DM, Fernstrom HA, Miller B & Krauss RM (1995) Apolipoprotein E isoform phenotype and LDL subclass response to a reduced-fat diet. Arteriosclerosis and Thrombosis 15, 105-111.
42. Driscoll DM & Casanova E (1990) Characterization of the apolipoprotein B mRNA editing activity in enterocyte extracts. Journal of Biological Chemistry 265, 21401-21403.
43. Dullaart RP, Hoogenberg K, Riemens SC, Groener JE, Van TA, Sluiter WJ & Stulp BK (1997) Cholesteryl ester transfer protein gene polymorphism is a determinant of HDL cholesterol and of the lipoprotein response to a lipid-lowering diet in type 1 diabetes. Diabetes 46, 2082-2087.
44. Eichner JE, Kuller LH, Ferrell RE & Kamboh MI (1989) Phenotypic effects of apolipoprotein structural variation on lipid profiles: II. Apolipoprotein A-IV and quantitative lipid measures in the healthy women study. Genetic Epidemiology 6, 493-499.
45. Expert Panel on High Blood Cholesterol in Adults (1993) Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Journal of the American Medical Association 269, 3015-3023.
46. Ferns GAA, Ritchie C, Stocks J & Galton DJ (1985) Genetic polymorphisms of apolipoprotein C-III and insulin in survivors of myocardial infarction. Lancet ii, 300-303.
47. Fielding CJ, Shore VG & Fielding PE (1972) A protein co-factor of lecithin:cholesterol acyltransferase. Biochemical and Biophysical Research Communications 46, 1493-1498.
48. Fisher EA, Blum CB, Zannis VI & Breslow JL (1983) Independent effects of dietary saturated fat and cholesterol on plasma lipids, lipoproteins, and apolipoprotein E. Journal of Lipid Research 24, 1039-1048.
49. Fisher L, FitzGerald GA & Lawn RM (1987) Two polymorphisms in the human lipoprotein lipase gene. Nucleic Acids Research 15, 7675.
50. Freeman DJ, Griffin BA, Holmes AP, Lindsay GM, Gaffney D, Packard CJ & Shepherd J (1994) Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors: Associations between the Taql B RFLP in the CETP gene and smoking and obesity. Arteriosclerosis and Thrombosis 14, 336-344.
51. Freeman DJ, Packard CJ, Shepherd J & Gaffney D (1990) Polymorphisms in the gene coding for cholesteryl ester transfer protein are related to plasma high-density lipoprotein cholesterol and transfer protein activity. Clinical Science 79, 575-581.
52. Friedl W, Ludwig EH, Paulweber B, Sandhofer F & McCarthy B (1990) Hypervariability in a minisatellite 3′ of the apolipoprotein B gene in patients with coronary heart disease compared with normal controls. Journal of Lipid Research 31, 659-665.
53. Friedlander Y, Berry EM, Eisenberg S, Stein Y & Leitersdorf E (1995) Plasma lipids and lipoproteins in response to a dietary challenge: analysis of four candidate genes. Clinical Genetics 47, 1-12.
54. Fumeron F, Betoulle D, Luc G, Behague I, Ricard B, Poirier O, Jemaa R, Evans A, Arveiler D, Marques-Vidal P, Bard, JM, Fruchart JC, Ducimetière P, Apfelbaum M & Cambien F (1995) Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. Journal of Clinical Investigation 96, 1664-1671.
55. Gaddi A, Ciarrocchi A, Matteucci A, Rimondi S, Ravaglia G, Descovich GC & Sirtori CR (1991) Dietary treatment for familial hypercholesterolemia-differential effects of dietary soy protein according to the apolipoprotein E phenotypes. American Journal of Clinical Nutrition 53, 1191-1196.
56. Genest JJ, Ordovas JM, McNamara JR, Robbins AM, Meade T, Cohn SD, Salem D, Wilson PWF, Masharani U, Frossard P & Schaefer EJ (1990) DNA polymorphisms of the apolipoprotein B gene in patients with premature coronary artery disease. Atherosclerosis 82, 7-17.
57. Ginsberg HN, Karmally W, Siddiqui M, Holleran S, Tall AR, Rumsey SC, Deckelbaum RJ, Blaner WS & Ramakrishnan R (1994) A dose-response study of the effects of dietary cholesterol on fasting and postprandial lipid and lipoprotein metabolism in healthy young men. Arteriosclerosis and Thrombosis 14, 576-586.
58. Glatz JFC, Demacker PNM, Turner PR & Katan MB (1991) Response of serum cholesterol to dietary cholesterol in relation to apolipoprotein E phenotype. Nutrition Metabolism and Cardiovascular Diseases 1, 13-17.
59. Goldberg IJ, Scheraldi CA, Yacoub LK, Saxena U & Bisgaier CL (1990) Lipoprotein apoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV. Journal of Biological Chemistry 265, 4266-4272.
60. Green PH, Glickman RM, Riley JW & Quinet E (1980) Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. Journal of Clinical Investigation 65, 911-919.
61. Hanis CL, Douglas TC & Hewett-Emmett D (1991) Apolipoprotein A-IV protein polymorphism: frequency and effects on lipids, lipoproteins, and apolipoproteins among Mexican-Americans in Starr County, Texas. Human Genetics 86, 323-325.
62. Hannuksela ML, Liinamaa MJ, Kesäniemi YA & Savolainen MJ (1994) Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. Atherosclerosis 110, 35-44.
63. Hegele RA, Huang LS & Herbert PN (1986) Apolipoprotein B gene DNA polymorphisms associated with myocardial infarction. New England Journal of Medicine 315, 1509-1515.
64. Heinzmann C, Ladias JA, Antonarakis SE, Kirchgessner T, Schotz MC & Lusis AJ (1987) RFLP for human lipoprotein lipase gene; Hindlll. Nucleic Acids Research 15, 6763.
65. Heliö T, Ludwig EH, Palotie A, Koskinen P, Paulweber B, Kauppinen-Mäkelin R, Manninen V, Manttari M, Frick MH, Ehnholm C & Tikkanen MJ (1991) Apolipoprotein B gene 3′ hypervariable region polymorphism and myocardial infarction in dyslipidemic Finnish men participating in a primary prevention trial. Nutrition Metabolism and Cardiovascular Diseases 1, 178-182.
66. Hixson JE, McMahan CA, McGill HC Jr, Strong JP & PDAY Research Group (1992) Apo B insertion/deletion polymorphisms are associated with atherosclerosis in young black but not young white males. Arteriosclerosis and Thrombosis 12, 1023-1029.
67. Hoeg JM, Sviridov DD, Tennyson GE, Demosky SJ Jr, Meng MS, Bojanovski D, Safonova IG, Repin VS, Kuberger MB, Smirnov VN, Higuchi K, Gregg RE & Brewer HB (1990) Both apolipoproteins B-48 and B-100 are synthesized and secreted by the human intestine. Journal of Lipid Research 31, 1761-1769.
68. Hoffer MJV, Bredie SJH, Boomsma DI, Reymer PWA, Kastelein JJP, de Knijff P, Demacker PNM, Stalenhoef AFH, Havekes LM & Frants RR (1996) The lipoprotein lipase (Asn291 → Ser) mutation is associated with elevated lipid levels in families with familial combined hyperlipidaemia. Atherosclerosis 119, 159-167.
69. Huang LS, de Graaf J & Breslow JL (1988) Apo B gene RFLP in exon 26 changes amino acid 3611 from Arg to GIn. Journal of Lipid Research 29, 63-67.
70. Humphries SE, Fisher R, Mailly F, Peacock R, Talmud P, Karpe F, Hamsten A & Miller GJ (1996) Gene-environment interaction in determining plasma lipids and dietary response: The effect of common mutations in the gene for lipoprotein lipase (D9N and N291S). In Nutrition, Genetics and Heart Disease, pp. 279-295 [Pennington Biomedical Research Center, editors]. Baton Rouge, LA: LSU Press.
71. Hunninghake DB, Stein EA, Dujovne CA, Harris WS, Feldman EB, Miller VT, Tobert JA, Laskarzewski PM, Quiter E, Held J, Taylor AM, Hopper S, Leonard SB & Brewer BK (1993) The efficacy of intensive dietary therapy alone or combined with lovastatin in outpatients with hypercholesterolemia. New England Journal of Medicine 328, 1213-1219.
72. Ito Y, Azrolan N, O'Connell A, Walsh A & Breslow JL (1990) Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice. Science 249, 790-793.
73. Jansen S, Lopez-Miranda J, Ordovas JM, Zambrana JL, Marin C, Oslos MA, Castro P, McPherson R, Lopez Segura F, Blanco A, Jimenez Pereperez JA & Perez-Jimenez F (1997a) Effect of 360His mutation in apolipoprotein A-IV on plasma HDL-cholesterol response to dietary fat. Journal of Lipid Research 38, 1995-2002.
74. Jansen S, Lopez-Miranda J, Salas J, Ordovas JM, Castro P, Marin C, Oslos MA, Lopez-Segura F, Jimenez-Pereperez JA, Blanco A & Perez-Jimenez F (1997b) Effect of 347-serine mutation in apoprotein A-IV on plasma LDL cholesterol response to dietary fat. Arteriosclerosis, Thrombosis and Vascular Biology 17, 1532-1538.
75. Jeenah M, Kessling A, Miller N & Humphries SE (1990) G to A substitution in the promoter region of the apoliprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. Molecular Biology and Medicine 7, 233-241.
76. Jenkins DJA, Hegele RA, Jenkins AL, Connelly PW, Hallak K, Bracci P, Kashtan H, Corey P, Pintilia M, Stern H & Bruce R (1993) The apolipoprotein E gene and the serum low-density lipoprotein cholesterol response to dietary fiber. Metabolism 42, 585-593.
77. 9Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. Circulation 94, 1913-1918.
78. Kamboh MI, Hamman RF, Iyengar S, Aston CE & Ferrell RE (1991) Apolipoprotein A-IV polymorphism, and its role in determining variation in lipoprotein-lipid, glucose and insulin levels in normal and non-insulin-dependent diabetic individuals. Atherosclerosis 91, 25-34.
79. Kamboh MI, Iyengar S, Aston CE, Hamman RF & Ferrell RE (1992) Apolipoprotein A-IV genetic polymorphism and its impact on quantitative traits in normoglycemic and non-insulin-dependent diabetic Hispanics from the San Luis Valley, Colorado. Human Biology 64, 605-616.
80. Kaprio J, Ferrell RE, Kottke BA, Kamboh MI & Sing CF (1991) Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease. Arteriosclerosis and Thrombosis 11, 1330-1348.
81. Karathanasis SK (1985) Apolipoprotein multigene family: tandem organization of human apolipoprotein A-I, C-III and A-IV genes. Proceedings of the National Academy of Sciences USA 82, 6374-6378.
82. Katan MB, Grundy SM & Willett WC (1997a) Should a low-fat, high-carbohydrate diet be recommended for everyone? Beyond low-fat diets. New England Journal of Medicine 337, 563-566.
83. Katan MB, Grundy SM & Willett WC (1997b) Should a low-fat, high-carbohydrate diet be recommended for everyone? Discussion. New England Journal of Medicine 337, 566-567.
84. Kesaniemi YA, Ehnholm C & Miettinen TA (1987) Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. Journal of Clinical Investigation 80, 578-581.
85. Kessling A, Ouellette S, Bouffard O, Chamberland A, Bétard C, Selinger E, Xhignesse M, Lussier-Cacan S & Davignon J (1991) Patterns of association between genetic variability in apolipoprotein (apo) B, apo AI-CIII-AIV, and cholesteryl ester transfer protein gene regions and quantitative variation in lipid and lipoprotein traits: Influence of gender and exogenous hormones. American Journal of Human Genetics 50, 92-106.
86. Kondo I, Berg K, Drayna DT & Lawn RM (1989) DNA polymorphism at the locus for human cholesteryl ester transfer protein (CETP) is associated with high density lipoprotein cholesterol and apolipoprotein levels. Clinical Genetics 35, 49-56.
87. Kowal RC, Herz J, Weisgraber KH, Mahley RW, Brown MS & Goldstein JL (1990) Opposing effects of apolipoprotein E and C on lipoprotein binding to low density lipoprotein receptor related protein. Journal of Biological Chemistry 265, 10771-10779.
88. Kuivenhoven JA, de Knijff P, Boer JMA, Smalheer HA, Botma GJ, Seidell JC, Kastelein JJP & Pritchard PH (1997) Heterogeneity at the CETP gene locus - Influence on plasma CETP concentrations and HDL cholesterol levels. Arteriosclerosis, Thrombosis and Vascular Biology 17, 560-568.
89. Kuivenhoven JA, Jukema JW, Zwinderman AH, de Knijff P, McPherson R, Bruschke AV, Lie KI & Kastelein JJ (1998) The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group. New England Journal of Medicine 338, 86-93.
90. Lau PP, Xiong W, Zhu H-J, Chen S-H & Chan L (1991) Apolipoprotein B mRNA editing is an intranuclear event that occurs posttranscriptionally coincident with splicing and polyadenylation. Journal of Biological Chemistry 266, 20550-20554.
91. Law A, Wallis SC, Powell LM, Pease RJ, Brunt H, Priestley LM, Knott TJ, Scott J, Altman DG, Miller GJ, Rajput J & Miller NE (1986) Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels. Lancet i, 1301-1302.
92. Law S, Lackner KJ, Hospattanakar AV, Anchors JM, Sakaguchi AY, Naylor SL & Brewer HB Jr (1985) Human apolipoprotein B-100: cloning, analysis of liver mRNA, and assignment of the gene to chromosome 2. Proceedings of the National Academy of Sciences USA 82, 8340-8344.
93. Lefevre M, Ginsberg HN, Kris-Etherton PM, Elmer PJ, Stewart PW, Ershow A, Pearson TA, Roheim PS, Ramakrishnan R, Derr J, Gordon DJ & Reed R (1997) ApoE genotype does not predict lipid response to changes in dietary saturated fatty acids in a heterogeneous normolipidemic population. The DELTA Research Group. Dietary effects on lipoproteins and thrombogenic activity. Arteriosclerosis, Thrombosis and Vascular Biology 17, 2914-2923.
94. Lehtimäki T, Frankberg-Lakkala H, Solakivi T, Koivisto A, Laippala P, Ehnholm C, Jokela H, Koivula T & Nikkari T (1997) The effect of short-term fasting, apolipoprotein E gene polymorphism, and sex on plasma lipids. American Journal of Clinical Nutrition 66, 599-605.
95. Lehtimäki T, Moilanen T, Porkka K, Åkerblom HK, Rönnemaa T, Räsänen L, Viikari J, Ehnholm C & Nikkari T (1995) Association between serum lipids and apolipoprotein E phenotype is influenced by diet in a population-based sample of free-living children and young adults: The Cardiovascular Risk in Young Finns Study. Journal of Lipid Research 36, 653-661.
96. Lehtimäki T, Moilanen T, Solakivi T, Laippala P & Ehnholm C (1992) Cholesterol-rich diet induced changes in plasma lipids in relation to apolipoprotein E phenotype in healthy students. Annals of Medicine 24, 61-66.
97. Levy E, Rochette C, Londono I, Roy CC, Milne RW, Marcel YL & Bendayan M (1990) Apolipoprotein B-100: immunolocalization and synthesis in human intestinal mucosa. Journal of Lipid Research 31, 1937-1946.
98. Li WW, Dammerman M, Smith JD, Metzger S, Halaas JL, Breslow JL & Leff T (1994) A common variant of the apo CIII promoter associated with hypertriglyceridemia is defective in its transcriptional response to insulin. Circulation 90, I-401 Abstr.
99. Li WW & Leff T (1994) Regulation of apolipoprotein CIII gene transcription by insulin: characterization of an insulin response element in the CIII promoter. Circulation 90, I-401 Abstr.
100. Loktionov A, Bingham SA, Vorster H, Jerling JC, Runswick SA & Cummings JH (1998) Apolipoprotein E genotype modulates the effect of black tea drinking on blood lipids and blood coagulation factors: a pilot study. British Journal of Nutrition 79, 133-139.
101. Lopez-Miranda J, Jansen S, Ordovas JM, Salas J, Marin C, Castro P, Ostos MA, Cruz G, Lopez-Segura F, Blanco A, Jimenez-Pereperez J & Perez-Jimenez F (1997a) Influence of the Sstl polymorphism at the apolipoprotein C-III gene locus on the plasma low-densily-lipoprotein-cholesterol response to dietary monounsaturated fat. American Journal of Clinical Nutrition 66, 97-103.
102. Lopez-Miranda J, Kam N, Osada J, Rodriguez C, Fernandez P, Contois J, Schaefer EJ & Ordovas JM (1994a) Effect of fat feeding on human intestinal apolipoprotein B mRNA levels and editing. Biochimica et Biophysica Acta 1214, 143-147.
103. Lopez-Miranda J, Ordovas JM, Espino A, Marin C, Salas J, Lopez-Segura F, Jimenez-Pereperez J & Perez-Jimenez F (1994b) Influence of mutation in human apolipoprotein A-1 gene promoter on plasma LDL cholesterol response to dietary fat. Lancet 343, 1246-1249.
104. Lopez-Miranda J, Ordovas JM, Mata P, Lichtenstein AH, Clevidence B, Judd JT & Schaefer EJ (1994c) Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol. Journal of Lipid Research 35, 1965-1975.
105. Lopez-Miranda J, Ordovas JM, Ostos MA, Marin C, Jansen S, Salas J, Blanco-Molina A, Jimenez-Pereperez JA, Lopez-Segura F & Perez-Jimenez F (1997b) Dietary fat clearance in normal subjects is modulated by genetic variation at the apolipoprotein B gene locus. Arteriosclerosis, Thrombosis and Vascular Biology 17, 1765-1773.
106. McCombs RJ, Marcadis DE, Ellis J & Weinberg RB (1994) Attenuated hypercholesterolemic response to a high-cholesterol diet in subjects heterozygous for the apolipoprotein A-IV-2 allele. New England Journal of Medicine 331, 706-710.
107. Mahley RW (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622-630.
108. Mailly F, Fisher RM, Nicaud V, Luong LA, Evans AE, Marques-Vidal P, Luc G, Arveiler D, Bard JM, Poirier O, Talmud PJ & Humphries SE (1996) Association between the LPL-D9N mutation in the lipoprotein lipase gene and plasma lipid traits in myocardial infarction survivors from the ECTIM study. Atherosclerosis 122, 21-28.
109. Manttari M, Kosninen P, Enholm C, Huttunen JK & Manninen V (1991) Apolipoprotein E polymorphism influences the serum cholesterol response to dietary intervention. Metabolism 40, 217-221.
110. Marshall HW, Morrison LC, Wu LL, Anderson JL, Corneli PS, Stauffer DM, Allen A, Karagounis LA & Ward RH (1994) Apolipoprotein polymorphisms fail to define risk of coronary artery disease: Results of a prospective, angiographically controlled study. Circulation 89, 567-577.
111. Martin LJ, Connelly PW, Nancoo D, Wood N, Zhang ZJ, Maguire G, Quinet E, Tall AR, Marcel YL & McPherson R (1993) Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: Relationship to apolipoprotein E genotype. Journal of Lipid Research 34, 437-446.
112. Mata P, Lopez-Miranda J, Pocovi M, Alonso R, Lahoz C, Marin C, Garces C, Cenarro A, Perez-Jimenez F, De Oya M & Ordovas JM (1998) Human apolipoprotein A-I gene promoter mutation influences plasma low density lipoprotein cholesterol response to dietary fat saturation. Atherosclerosis 137, 367-376.
113. Mata P, Ordovas JM, Lopez-Miranda J, Lichtenstein AH, Clevidence BA, Judd JT & Schaefer EJ (1994) ApoA-IV phenotype affects diet-induced plasma LDL cholesterol lowering. Arteriosclerosis and Thrombosis 14, 884-891.
114. Mattei MG, Etienne J, Chuat JC, Nguyen VC, Brault D, Bernheim A & Galibert F (1993) Assignment of the human lipoprotein lipase (LPL) gene to chromosome band 8p22. Cytogenetics and Cell Genetics 63, 45-16.
115. Meng QH, Pajukanta P, Valsta L, Aro A, Pietinen P & Tikkanen MJ (1997) Influence of apolipoprotein A-1 promoter polymorphism on lipid levels and responses to dietary change in Finnish adults. Journal of Internal Medicine 241, 373-378.
116. Menzel HJ, Boerwinkle E, Schrangl-Will S & Utermann G (1988) Human apolipoprotein A-IV polymorphism: frequency and effect on lipid and lipoprotein levels. Human Genetics 79, 368-372.
117. Menzel HJ, Sigurdsson G, Boerwinkle E, Schrangl-Will S, Dieplinger H & Utermann G (1990) Frequency and effect of human apolipoprotein A-IV polymorphism on lipid and lipoprotein levels in an Icelandic population. Human Genetics 84, 344-346.
118. Miettinen TA, Gylling H & Vanhanen H (1988) Serum cholesterol response to dietary cholesterol and apoprotein E phenotype. Lancet ii, 1261.
119. Miettinen TA, Gylling H, Vanhanen H & Ollus A (1992) Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes. Arteriosclerosis and Thrombosis 12, 1044-1052.
120. Minnich A, DeLangavant G, Lavigne J, Roederer G, Lussier-Cacan S & Davignon J (1995) G-> A substitution at position -75 of the apolipoprotein A-I gene promoter - Evidence against a direct effect on HDL cholesterol levels. Arteriosclerosis, Thrombosis and Vascular Biology 15, 1740-1745.
121. Monsalve MV, Young R, Jobsis J, Wiseman SA, Dhamu S, Powell JT, Greenhalgh RM & Humphries SE (1988) DNA polymorphism of the gene for apolipoprotein B in patients with peripheral arterial disease. Atherosclerosis 70, 123-129.
122. Myant NB, Gallagher J, Barbir M, Thompson GR, Wile DB & Humphries SE (1989) Restriction fragment length polymorphism in the apo B gene in relation to coronary artery disease. Atherosclerosis 71, 193-201.
123. Needham EWA, Mattu RK, Rees A, Stocks J & Galton DJ (1994) A polymorphism in the human apolipoprotein AI promoter region: A study in hypertriglyceridaemic patients. Human Heredity 44, 94-99.
124. Nikkilä M, Solakivi, T, Lehtimäki T, Koivula T, Laippala P & Astrom B (1994) Postprandial plasma lipoprotein changes in relation to apolipoprotein E phenotypes and low density lipoprotein size in men with and without coronary artery disease. Atherosclerosis 106, 149-157.
125. Nilsson-Ehle P, Garfinkle AS & Schotz MC (1980) Lipolytic enzymes and plasma lipoprotein metabolism. Annual Review of Biochemistry 49, 667-693.
126. Oka K, Tkalcevic GT, Wakano T, Tucker H, Ishimura-Oka K & Brown WV (1990) Structure and polymorphic map of human lipoprotein lipase. Biochimica et Biophysica Acta 1049, 21-26.
127. Ordovas JM, Cassidy DK, Civeira F, Bisgaier CL & Schaefer EJ (1989) Familial apolipoprotein A-I, C-III, and A-IV deficiency and premature atherosclerosis due to a deletion of a gene complex on chromosome 11. Journal of Biological Chemistry 264, 16339-16342.
128. Ordovas JM, Civeira F, Garces C & Pocovi M (1991a) Genetic variation at the apolipoprotein A-I, C-III, A-IV gene complex. In DNA Polymorphisms as Disease Markers, pp. 91-105 [DJ Galton, editor]. New York: Plenum Press.
129. Ordovas JM, Civeira F, Genest J Jr, Craig S, Robbins AH, Meade T, Pocovi M, Frossard PM, Masharani U, Wilson PW Salem DN, Ward RH & Schaefer EJ (1991b) Restriction fragment length polymorphisms of the apolipoprotein A-I, C-III, A-IV gene locus. Relationships with lipids, apolipoproteins, and premature coronary artery disease. Atherosclerosis 87, 75-86.
130. Ordovas JM, Litwack-Klein L, Wilson PWF, Schaefer MM & Schaefer EJ (1987) Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. Journal of Lipid Research 28, 371-380.
131. Ordovas JM, Lopez-Miranda J, Perez-Jimenez F, Rodriguez CR, Park J, Cole
132. Orth M, Wahl S, Hanisch M, Friedrich I, Wieland H & Luley C (1996) Clearance of post-prandial lipoproteins in normolipemics: Role of the apolipoprotein E phenotype. Biochimica et Biophysica Acta 1303, 22-30.
133. Pagani F, Giudici GA, Baralle FE & Vergani C (1992) Association of a polymorphism in the apoA-I gene promoter with hyperalphalipoproteinemia. European Journal of Epidemiology 8, Suppl. 1, 54-58.
134. Pagani F, Sidoli A, Giudici GA, Barenghi L, Vergani C & Baralle FE (1990) Human apolipoprotein A-I gene promoter polymorphism: Association with hyperalphalipoproteinemia. Journal of Lipid Research 31, 1371-1377.
135. Park S, Snook JT, Bricker L, Morroco M, Van Voorhis R, Stasny E & Lee MS (1996) Relative effects of high saturated fatty acid levels in meat, dairy products, and tropical oils on serum lipoproteins and low-density lipoprotein degradation by mononuclear cells in healthy males. Metabolism 45, 550-558.
136. Pasagian-Macaulay A, Aston CE, Ferrell RE, McAllister A, Wing RR & Kuller LH (1997) A dietary and behavioral intervention designed to lower coronary heart disease. Risk factors are unaffected by variation at the APOE gene locus. Atherosclerosis 132, 221-227.
137. Paul-Hayase H, Rosseneu M, Robinson D, Van Bervliet JP, Deslypere JP & Humphries SE (1992) Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: Detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations. Human Genetics 88, 439-446.
138. Peacock RE, Dunning A, Hamsten A, Tornvall P, Humphries S & Talmud P (1992a) Apolipoprotein B gene polymorphisms, lipoproteins and coronary atherosclerosis: A study of young myocardial infarction survivors and healthy population-based individuals. Atherosclerosis 92, 151-164.
139. Peacock RE, Hamsten A, Johansson J, Nilsson-Ehle P & Humphries SE (1994) Associations of genotypes at the apoliprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses. Clinical Genetics 46, 273-282.
140. Peacock RE, Hamsten A, Nilsson-Ehle P & Humphries SE (1992b) Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. Atherosclerosis 97, 171-185.
141. Pimstone SN, Clee SM, Gagné SE, Miao L, Zhang HF, Stein EA & Hayden MR (1996) A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) results in altered postprandial chylomicron triglyceride and retinyl palmitate response in normolipidemic carriers. Journal of Lipid Research 37, 1675-1684.
142. Pimstone SN, Gagné SE, Gagné C, Lupien PJ, Gaudet D, Williams RR, Kotze M, Reymer PWA, Defesche JC, Kastelein JJP, Moorjani S & Hayden MR (1995) Mutations in the gene for lipoprotein lipase - A cause for low HDL cholesterol levels in individuals heterozygous for familial hypercholesterolemia. Arteriosclerosis, Thrombosis and Vascular Biology 15, 1704-1712.
143. Rader DJ, Schäfer J, Lohse P, Verges B, Kindt M, Zech LA, Steinmetz A & Brewer HB Jr (1993) Rapid in vivo transport and catabolism of human apolipoprotein A-IV-1 and slower catabolism of the ApoA-IV-2 isoprotein. Journal of Clinical Investigation 92, 1009-1017.
144. Régis-Bailly A, Fournier B, Steinmetz J, Gueguen R, Siest G & Visvikis S (1995) Apo B signal peptide insertion deletion polymorphism is involved in postprandial lipoparticles' responses. Atherosclerosis 118, 23-34.
145. Reichl D & Miller NE (1989) Pathophysiology of reverse cholesterol transport: Insights from inherited disorders of lipoprotein metabolism. Arteriosclerosis 9, 785-797.
146. Reymer PWA, Groenemeyer BE, Gagne E, Miao L, Appelman EEG, Seidel JC, Kromhout D, Bijvoet SM, Van de Oever K, Bruin T, Hayden MR & Kastelein JJP (1995) A frequently occurring mutation in the lipoprotein lipase gene (Asn291Ser) contributes to the expression of familial combined hyperlipidemia. Human Molecular Genetics 4, 1543-1549.
147. Reznik Y, Pousse P, Herrou M, Morello R, Mahoudeau J, Drosdowsky MA & Fradin S (1996) Postprandial lipoprotein metabolism in normotriglyceridemic non-insulin-dependent diabetic patients: Influence of apolipoprotein E polymorphism. Metabolism 45, 63-71.
148. Saha N, Tay JSH & Chew LS (1992) Influence of apolipoprotein B signal peptide insertion/deletion polymorphism on serum lipids and apolipoproteins in a Chinese population. Clinical Genetics 41, 152-156.
149. Saha N, Tay JSH, Low PS & Humphries SE (1994) Guanidine to adenine (G/A) substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI levels in Chinese non-smokers. Genetic Epidemiology 11, 255-264.
150. Sarkkinen ES, Uusitupa MIJ, Pietinen P, Aro A, Ahola I, Penttilä I, Kervinen K & Kesäniemi YA (1994) Long-term effects of three fat-modified diets in hypercholesterolemic subjects. Atherosclerosis 105, 9-23.
151. Savolainen MJ, Rantala M, Kervinen K, Jarvi L, Suvanto K, Rantala T & Kesäniemi YA (1991) Magnitude of dietary effects on plasma cholesterol concentration: role of sex and apolipoprotein E phenotype. Atherosclerosis 86, 145-152.
152. Schaefer EJ, Gregg RE, Ghiselli G; Forte TM, Ordovas JM, Zech LA, Lindgren FT & Brewer HB Jr (1986) Familial apolipoprotein E deficiency. Journal of Clinical Investigation 78, 1206-1219.
153. Schaefer EJ, Lamon-Fava S, Johnson S, Ordovas JM, Schaefer MM, Castelli WP & Wilson PWF (1994) Apolipoprotein E phenotype affects plasma lipoprotein levels in a gender- and menopausal status-dependent manner. Arteriosclerosis and Thrombosis 14, 1105-1113.
154. Schaefer EJ, Lichtenstein AH, Lamon-Fava S, Contois JH, Li Z, Rasmussen H, McNamara JR & Ordovas JM (1995) Efficacy of a National Cholesterol Education Program Step 2 diet in normolipidemic and hypercholesterolemic middle-aged and elderly men and women. Arteriosclerosis, Thrombosis and Vascular Biology 15, 1079-1085.
155. Sigurdsson G Jr, Gudnason V, Sigurdsson G & Humphries SE (1992) Interaction between a polymorphism of the Apo A-I promoter region and smoking determines plasma levels of HDL and Apo A-I. Arteriosclerosis and Thrombosis 12, 1017-1022.
156. Smith JD, Brinton EA & Breslow JL (1992) Polymorphism in the human apolipoprotein A-I gene promoter region. Association of the minor allele with decreased production rate in vivo and promoter activity in vitro. Journal of Clinical Investigation 89, 1796-1800.
157. Stein O, Stein Y, Lefevre M & Roheim PS (1986) The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from an ether analog of phosphatidylcholine. Biochimica et Biophysica Acta 878, 7-13.
158. Steinmetz A, Barbaras R, Ghalim N, Clavey V, Fruchart JC & Ailhaud G (1990) Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells. Journal of Biological Chemistry 265, 7859-7863.
159. Steinmetz A & Utermann G (1985) Activation of lecithinxholesterol acyltransferase by human apolipoprotein A-IV. Journal of Biological Chemistry 260, 2258-2264.
160. Stocks J, Thorn JA & Galton DJ (1992) Lipoprotein lipase genotypes for a common premature termination codon mutation detected by PCR-mediated site-directed mutagenesis and restriction digestion. Journal of Lipid Research 33, 853-857.
161. Superko HR & Haskell WL (1991) The effect of apolipoprotein E isoform difference on postprandial lipoproteins in patients matched for triglycerides, LDL-cholesterol, and HDL-cholesterol. Artery 18, 315-325.
162. Tall A, Welch C, Applebaum-Bowden D & Wassef M (1997) Interaction of diet and genes in atherogenesis. Report of an NHLBI working group. Arteriosclerosis, Thrombosis and Vascular Biology 17, 3326-3331.
163. Talmud PJ, Barni N & Kessling AM (1987) Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels: a study in normo- and hyperlipidemic individuals. Atherosclerosis 67, 81-89.
164. Talmud PJ, Boerwinkle E, Xu C, Tikkanen MJ, Pietinen P, Huttunen JK & Humphries S (1992) Dietary intake and gene variation influence the response of plasma lipids to dietary intervention. Genetic Epidemiology 9, 249-260.
165. Talmud PJ, Peacock R, Karpe F, Hamsten A & Humphries S (1996) ApoB genetic variants modulate postprandial lipoprotein metabolism. In Nutrition, Genetics and Heart Disease, pp. 366-378 [Pennington Biomedical Research Center, editors]. Baton Rouge, LA: LSU Press.
166. Talmud PJ, Ye S & Humphries SE (1994) Polymorphism in the promoter region of the apolipoprotein AI gene associated with differences in apolipoprotein AI levels: The European Atherosclerosis Research Study. Genetic Epidemiology 11, 265-280.
167. Thorn JA, Chamberlain JC, Alcolado JC, Oka K, Chan L, Stocks J & Galton DJ (1990) Lipoprotein and hepatic lipase gene variants in coronary atherosclerosis. Atherosclerosis 85, 55-60.
168. Tikkanen MJ, Huttunen JK, Enholm C & Pietinen P (1990a) Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high fat diet. Arteriosclerosis 10, 285-288.
169. Tikkanen MJ, Xu C-F, Hamalainen T, Talmud P, Sama S, Huttunen JK, Pietinen P & Humphries S (1990b) Xbal polymorphism of the apolipoprotein B gene influences plasma lipid response to diet intervention. Clinical Genetics 37, 327-334.
170. Tso TK, Park S, Tsai YH, Williams G & Snook JT (1998) Effect of apolipoprotein E polymorphism on serum lipoprotein response to saturated fatty acids. Lipids 33, 139-148.
171. Tuteja R, Tuteja N, Melo C, Casari G & Baralle FE (1992) Transcription efficiency of human apolipoprotein A-I promoter varies with naturally occurring A to G transition. FEBS Letters 304, 98-101.
172. Tybjaerg-Hansen A, Nordestgaard BG, Gerdes LU, Faergeman O & Humphries SE (1993) Genetic markers in the apo AI-CIII-AIV gene cluster for combined hyperlipidemia, hypertriglyceridemia, and predisposition to atherosclerosis. Atherosclerosis 100, 157-169.
173. Uusitupa MIJ, Ruuskanen E, Mäkinen E, Laitinen J, Toskala E, Kervinen K & Kesäniemi YA (1992) A controlled study on the effect of beta-glucan-rich oat bran on serum lipids in hypercholesterolemic subjects: Relation to apolipoprotein E phenotype. Journal of the American College of Nutrition 11, 651-659.
174. Visvikis S, Cambou JP, Arveiler D, Evans AE, Parra HJ, Aguillon D, Fruchart JC, Siest G & Cambien F (1993) Apolipoprotein B signal peptide polymorphism in patients with myocardial infarction and controls. 'The ECTIM study'. Human Genetics 90, 561-565.
175. Von Eckardstein A, Funke H, Schulte M, Erren M, Schulte H & Assmann G (1992) Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associated with changes in the concentration of apo B- and apo A-I-containing lipoproteins in a normal population. American Journal of Human Genetics 50, 1115-1128.
176. Wang CS, McConathy WJ, Kloer HU & Alaupovic P (1985) Modulation of lipoprotein lipase activity by lipoproteins. Effect of apolipoprotein C-III. Journal of Clinical Investigation 75, 384-390.
177. Weinberg RB & Patton CS (1990) Binding of human apolipoprotein A-IV to human hepatocellular plasma membranes. Biochimica et Biophysica Acta 1044, 255-261.
178. Weintraub MS, Eisenberg S & Breslow JL (1987) Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. Journal of Clinical Investigation 80, 1571-1577.
179. Weisgraber KH, Mahley RW, Kowal RC, Herz J, Goldstein JL & Brown MS (1990) Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein. Journal of Biological Chemistry 265, 22453-22459.
180. Wolever TM, Hegele RA, Connelly PW, Ransom TP, Story J, Furumoto EJ & Jenkins DJ (1997) Long-term effect of soluble-fiber foods on postprandial fat metabolism in dyslipidemic subjects with apo E3 and apo E4 genotypes. American Journal of Clinical Nutrition 66, 584-590.
181. Xu C-F, Angelico F, Del Ben M & Humphries S (1993) Role of genetic variation at the apo AI-CIII-AIV gene cluster in determining plasma apo AI levels in boys and girls. Genetic Epidemiology 10, 113-122.
182. Xu C-F, Boerwinkle E, Tikkanen MJ, Huttunen JK & Humphries SE (1990a) Genetic variation at the apolipoprotein gene loci contribute to response of plasma lipids to dietary change. Genetic Epidemiology 7, 261-275.
183. Xu C-F, Tikkanen MJ, Butler R, Huttunen JK, Pietinen P, Humphries S & Talmud P (1990b) Apolipoprotein B signal peptide insertion/deletion polymorphism is associated with Ag epitopes and involved in the determination of serum triglyceride levels. Journal of Lipid Research 31, 1255-1261.
184. Zaiou M, Visvikis S, Gueguen R, Parra H-J, Fruchart JC & Siest G (1994) DNA polymorphisms of human apolipoprotein A-IV gene: frequency and effects on lipid, lipoprotein and apolipoprotein levels in a French population. Clinical Genetics 46, 248-254.
185. Zambón D, Ros E, Casals E, Sanllehy C, Bertomeu A & Campero I (1995) Effect of apolipoprotein E polymorphism on the serum lipid response to a hypolipidemic diet rich in monounsaturated fatty acids in patients with hypercholesterolemia and combined hyperlipidemia. American Journal of Clinical Nutrition 61, 141-148.
186. Zannis VI, Cole FS, Jackson CL, Kurnit DM & Karathanasis SK (1985) Distribution of apolipoprotein A-I, C-II, C-III, and E mRNA in fetal human tissues. Time-dependent induction of apolipoprotein E mRNA by cultures of human monocyte-macrophages. Biochemistry 24, 4450-4455.